MedVellum
MedVellum
Back to Library
Dermatology
Allergy
Immunology
General Practice

Urticaria

High EvidenceUpdated: 2025-12-24

On This Page

Red Flags

  • Anaphylaxis (Airway Compromise, Hypotension, Angioedema)
  • Urticarial Vasculitis (Painful, >24h Duration, Bruising, Systemic Symptoms)
  • Angioedema without Urticaria (Consider Hereditary Angioedema)
Overview

Urticaria

1. Clinical Overview

Summary

Urticaria (Hives) is a common condition characterised by itchy wheals (raised, erythematous, oedematous lesions) that result from mast cell degranulation and histamine release in the superficial dermis. Individual wheals are typically fleeting (resolve within 24 hours) and intensely itchy (not painful). Urticaria is classified as Acute (less than 6 weeks, often allergic or viral) or Chronic (≥6 weeks, most commonly Chronic Spontaneous Urticaria [CSU], often autoimmune). Angioedema (deeper dermal/submucosal swelling) may accompany urticaria. First-line treatment is non-sedating H1 antihistamines (Cetirizine, Fexofenadine, Loratadine), which can be increased up to 4x licensed dose in chronic refractory cases. Omalizumab (Anti-IgE antibody) is highly effective for severe CSU. Always exclude Anaphylaxis in acute presentations with systemic symptoms. [1,2]

Clinical Pearls

Fleeting Wheals (Each less than 24h): If individual lesions last >24 hours and are painful or leave bruising, consider Urticarial Vasculitis – different condition requiring investigation.

Chronic = Usually Autoimmune (CSU): Chronic Spontaneous Urticaria is often due to autoantibodies against IgE receptor. No external trigger found.

Up to 4x Antihistamine Dose: Standard dose often insufficient. Guidelines endorse increasing up to 4x licensed dose before escalating therapy.

Omalizumab Works: Anti-IgE monoclonal antibody is highly effective for CSU refractory to antihistamines.


2. Epidemiology

Prevalence

  • Lifetime Prevalence: ~20% (Very common).
  • Acute Urticaria: Much more common than Chronic.
  • Chronic Urticaria: ~1% of population. Female > Male (2:1).

Classification

TypeDurationCommon Causes
Acute Urticarialess than 6 weeksViral infection (Most common, especially in children). Allergic reaction (Food, Drug). Often idiopathic.
Chronic Urticaria≥6 weeksChronic Spontaneous Urticaria (CSU) – No identifiable trigger. Chronic Inducible Urticaria – Triggered by physical factors.

Chronic Inducible Urticarias (Physical Urticarias)

SubtypeTrigger
DermographismStroking/Scratching skin. "Skin Writing". Very common.
Cholinergic UrticariaHeat, Exercise, Sweating. Small (1-3mm) wheals.
Cold UrticariaCold exposure (Air, Water). Risk of anaphylaxis with cold water immersion.
Pressure UrticariaSustained pressure (Delayed). Painful.
Solar UrticariaSunlight exposure.
Aquagenic UrticariaWater contact (Any temperature). Rare.

3. Pathophysiology

Mechanism

  1. Mast Cell Activation: Trigger (IgE-mediated allergy, Autoantibodies, Physical stimulus, Unknown) activates cutaneous mast cells.
  2. Degranulation: Release of preformed mediators from mast cell granules.
  3. Histamine Release: Primary mediator. Causes vasodilation, increased vascular permeability, sensory nerve stimulation.
  4. Wheal Formation: Plasma extravasation into superficial dermis → Oedema → Raised, erythematous, oedematous lesion.
  5. Itch: Histamine stimulates cutaneous sensory nerves.
  6. Resolution: Wheals typically resolve within 24 hours as mediators are cleared.

Chronic Spontaneous Urticaria (CSU) – Autoimmune Mechanism

  • Type I Autoimmune CSU: Autoantibodies against IgE itself.
  • Type IIb Autoimmune CSU: Autoantibodies against the high-affinity IgE receptor (FcεRI) on mast cells → Direct mast cell activation.
  • Explains why Omalizumab (Anti-IgE) is effective.

4. Differential Diagnosis
ConditionKey Features
UrticariaWheals. Itchy. Each lesion lasts less than 24h. No bruising. Blanching.
Urticarial VasculitisWheals last >24h. Painful (Not just itchy). Leaves Purpura/Bruising (Post-inflammatory hyperpigmentation). May have systemic symptoms (Fever, Arthralgia). Biopsy shows Leukocytoclastic vasculitis.
AnaphylaxisUrticaria + Systemic symptoms: Hypotension, Bronchospasm, Angioedema (Airway). Emergency.
Angioedema without UrticariaDeeper swelling (Lips, Face, Tongue, Genitals, Bowel). Consider Hereditary Angioedema (HAE) – C1-esterase inhibitor deficiency. Or ACEi-induced.
Erythema MultiformeTarget lesions. Fixed (Don't move). History of HSV or drug.
Bullous Pemphigoid (Prebullous)Urticarial plaques. Elderly. Evolves to tense blisters.
MastocytosisUrticaria Pigmentosa – Tan/Brown macules that urticate on rubbing (Darier's Sign). Systemic symptoms.

5. Clinical Presentation

Wheals (The Hallmark)

FeatureDescription
AppearanceRaised, Oedematous, Erythematous. Central pallor may be present. Variable size (mm to cm).
DistributionAny part of body. Often generalised.
DurationIndividual wheal lasts less than 24 hours (Usually 30 mins to few hours). May see new ones appearing as old resolve.
ItchIntensely Itchy. Not painful (Pain suggests vasculitis).
BlanchingWheals blanch on pressure (Unlike purpura).

Angioedema (May Accompany ~50%)

Symptoms to Elicit


Swelling of deeper dermis/subcutaneous tissue.
Common presentation.
Affects Lips, Eyelids, Face, Hands, Feet, Genitals.
Common presentation.
Less itchy, more "pressure" sensation.
Common presentation.
Concerning if Tongue/Larynx involvement → Airway compromise.
Common presentation.
6. Investigations

Acute Urticaria

  • Usually No Investigations Needed: Self-limiting. History to identify trigger.
  • Allergy Testing: Only if clear history suggests specific allergen (e.g., Food, Drug).

Chronic Urticaria (≥6 Weeks)

TestRationale
FBCEosinophilia (Parasitic, Allergic).
ESR / CRPElevated in Urticarial Vasculitis.
TFTsThyroid autoimmunity associated with CSU.
Allergy Testing (Skin Prick / Specific IgE)Low yield in CSU (Not usually IgE-mediated). Consider if history suggests allergy.
Complement (C3, C4, C1-Esterase Inhibitor)If Angioedema without Urticaria or Family history → Exclude Hereditary Angioedema (HAE).
ANAIf vasculitis or connective tissue disease suspected.
Skin BiopsyIf lesions last >24h, Painful, or leave bruising – Exclude Urticarial Vasculitis.

Challenge Tests (For Inducible Urticarias)

SubtypeTest
DermographismStroke skin with firm object.
Cold UrticariaIce cube test (Ice on forearm 5 mins).
CholinergicExercise challenge.

7. Management

Management Algorithm

       URTICARIA PRESENTATION
                     ↓
       EXCLUDE ANAPHYLAXIS
       (Airway compromise, Hypotension, Systemic symptoms?)
    ┌────────────────┴────────────────┐
   YES (ANAPHYLAXIS)                 NO
    ↓                                 ↓
 EMERGENCY Rx                    ASSESS DURATION
 - IM Adrenaline                 
 - ABCDE                         ┌─────────────┴─────────────┐
 - See Anaphylaxis              ACUTE (less than 6 weeks)        CHRONIC (≥6 weeks)
   Pathway                            ↓                      ↓
                                 Often self-limiting    CHRONIC SPONTANEOUS
                                 + H1 Antihistamine     URTICARIA (CSU)
                                 + Identify/Avoid       or INDUCIBLE
                                   Trigger           
                     ↓
       FIRST-LINE: NON-SEDATING H1 ANTIHISTAMINES
    ┌──────────────────────────────────────────────────────────┐
    │  Cetirizine 10mg OD  OR  Fexofenadine 180mg OD  OR      │
    │  Loratadine 10mg OD                                      │
    │                                                          │
    │  If inadequate control after 2-4 weeks:                  │
    │  → INCREASE DOSE UP TO 4x LICENSED DOSE                  │
    │    (e.g., Cetirizine 10mg QDS / Fexofenadine 180mg QDS)  │
    │    (Off-label but evidence-based and guideline endorsed) │
    └──────────────────────────────────────────────────────────┘
                     ↓
       INADEQUATE RESPONSE TO 4x ANTIHISTAMINE?
    ┌────────────────┴────────────────┐
   YES                               NO
    ↓                                 ↓
 SECOND-LINE OPTIONS             CONTINUE +
                                 REVIEW PERIODICALLY
    ┌──────────────────────────────────────────────────────────┐
    │  ADD Leukotriene Antagonist (Montelukast 10mg OD)       │
    │  - Modest benefit. Can try for 4 weeks.                  │
    │                                                          │
    │  ADD H2 Antihistamine (Ranitidine 150mg BD - Note:       │
    │       Availability issues; Famotidine alternative)       │
    │  - Weak evidence.                                        │
    └──────────────────────────────────────────────────────────┘
                     ↓
       STILL REFRACTORY?
    ┌──────────────────────────────────────────────────────────┐
    │  REFER TO DERMATOLOGY / ALLERGY                          │
    │                                                          │
    │  THIRD-LINE: OMALIZUMAB (Xolair)                         │
    │  - Anti-IgE Monoclonal Antibody.                         │
    │  - 300mg SC every 4 weeks.                               │
    │  - Highly effective for CSU (~70-80% respond).           │
    │  - Specialist initiation.                                │
    │                                                          │
    │  OTHER OPTIONS (Specialist):                             │
    │  - Ciclosporin (Immunosuppressant – Off-label).          │
    │  - Short course Oral Steroids (For acute flares ONLY –   │
    │    NOT long-term).                                       │
    └──────────────────────────────────────────────────────────┘

Treatment Summary

LineTreatmentNotes
1st LineNon-Sedating H1 Antihistamine (Standard Dose)Cetirizine, Fexofenadine, Loratadine, Bilastine.
1st Line (Escalated)H1 Antihistamine up to 4x DoseIf suboptimal response. Off-label but guideline endorsed.
2nd LineAdd Montelukast (Leukotriene Antagonist)Modest benefit.
3rd LineOmalizumab (Anti-IgE)Specialist. Highly effective for CSU.
RefractoryCiclosporin (Immunosuppressant)Specialist. Off-label.
Acute Flares OnlyShort-course Oral PrednisoloneMax 3-5 days. Avoid long-term steroids.

Avoid

  • Long-term Oral Corticosteroids: Side effects outweigh benefits.
  • Sedating Antihistamines (Chlorphenamine, Promethazine): Sedation, Anticholinergic effects. Avoid as first-line (May use at night in some cases).

8. Complications
ComplicationNotes
AnaphylaxisIf urticaria is part of systemic allergic reaction. Medical emergency.
Angioedema (Airway)Tongue/Laryngeal swelling → Asphyxiation.
Quality of Life ImpactChronic urticaria significantly impacts sleep, work, mood.
Underlying DiseaseUrticarial Vasculitis may indicate Lupus or other CTD.

9. Prognosis and Outcomes
  • Acute Urticaria: Usually self-limiting (Days to weeks).
  • Chronic Spontaneous Urticaria (CSU): Variable. ~50% resolve within 1-3 years. Some persist for years.
  • Omalizumab: Excellent response rates (~70-80%). Symptoms may return on stopping.

10. Evidence and Guidelines

Key Guidelines

GuidelineOrganisationKey Recommendations
BSACI Urticaria GuidelinesBSACINon-sedating H1 antihistamines first-line. Up to 4x dose. Omalizumab for refractory CSU.
EAACI/GA²LEN/EDF/WAO Urticaria GuidelinesInternational (2022 Update)Similar. Comprehensive grading system.

11. Patient and Layperson Explanation

What is Urticaria (Hives)?

Urticaria (also called "Hives" or "Nettle Rash") is a condition where you get itchy, raised, red bumps on the skin (called "wheals"). They can appear anywhere on the body and usually come and go quickly – each bump usually lasts less than 24 hours.

What causes it?

In many cases, no specific cause is found. Sometimes it's triggered by an allergy (food, medication), an infection (like a cold), or a physical factor (cold, heat, pressure). In chronic cases (lasting more than 6 weeks), the immune system often mistakenly triggers the skin reaction without an external cause.

Is it serious?

Usually, urticaria is uncomfortable but not dangerous. However, if you have swelling of the lips, tongue, or throat, or difficulty breathing, this is an emergency (anaphylaxis) – call 999.

How is it treated?

The main treatment is antihistamine tablets (like Cetirizine or Fexofenadine). You may need to take a higher dose than usual. Most cases get better over time, but some people need specialist treatments like Omalizumab (an injection).


12. References

Primary Sources

  1. Zuberbier T, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-766. PMID: 34536239.
  2. Powell RJ, et al. BSACI guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy. 2015;45(3):547-65. PMID: 25711134.

13. Examination Focus

Common Exam Questions

  1. Duration of Individual Wheal: "How long does each individual wheal last in typical urticaria?"
    • Answer: less than 24 hours.
  2. Urticarial Vasculitis Clue: "What feature suggests Urticarial Vasculitis rather than simple Urticaria?"
    • Answer: Wheals lasting >24 hours, Painful (not just itchy), Leave bruising/Purpura.
  3. First-Line Treatment: "First-line treatment for Chronic Spontaneous Urticaria?"
    • Answer: Non-sedating H1 Antihistamine (Cetirizine, Fexofenadine, Loratadine), up to 4x licensed dose if needed.
  4. Third-Line Treatment: "Biologic therapy for refractory CSU?"
    • Answer: Omalizumab (Anti-IgE Monoclonal Antibody).

Viva Points

  • 4x Dose Antihistamines: Explain this is guideline-endorsed, off-label use.
  • Dermographism Test: Demonstrate/describe.

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.

Last updated: 2025-12-24

At a Glance

EvidenceHigh
Last Updated2025-12-24

Red Flags

  • Anaphylaxis (Airway Compromise, Hypotension, Angioedema)
  • Urticarial Vasculitis (Painful, >24h Duration, Bruising, Systemic Symptoms)
  • Angioedema without Urticaria (Consider Hereditary Angioedema)

Clinical Pearls

  • **Fleeting Wheals (Each less than 24h)**: If individual lesions last >24 hours and are painful or leave bruising, consider **Urticarial Vasculitis** – different condition requiring investigation.
  • **Chronic = Usually Autoimmune (CSU)**: Chronic Spontaneous Urticaria is often due to autoantibodies against IgE receptor. No external trigger found.
  • **Up to 4x Antihistamine Dose**: Standard dose often insufficient. Guidelines endorse increasing up to 4x licensed dose before escalating therapy.
  • **Omalizumab Works**: Anti-IgE monoclonal antibody is highly effective for CSU refractory to antihistamines.

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines